PENTA guidelines for the use of antiretroviral therapy, 2004

HIV Medicine
Mike SharlandPENTA Steering Committee

Abstract

There have been few major advances in paediatric HIV management over the last 2 years. Decisions about starting antiretroviral therapy can now be based on a recent large meta-analysis of the predictive value of CD4 and HIV RNA viral load (VL) in nearly 4000 untreated children, which is discussed in these updated guidelines. Risk estimates for progression to AIDS and death using surrogate markers can now be broken down by age, allowing more accurate discussion with families. In addition, there is increasing recognition of the problems of long-term adherence, drug resistance and cumulative toxicity in adults and children. The controversy over whether to treat asymptomatic infants continues. For older children more data on the efficacy of ritonavir boosted protease inhibitor (PI) regimens suggests that these may be the PI option of first choice. There is still no adult or paediatric trial evidence on which to base decisions about whether to start with PI- or non-nucleoside reverse transcriptase inhibitor (NNRTI)- based regimens, but the PENPACT 1 trial, which is addressing this question, is ongoing. There are increasing moves to provide simpler antiretroviral therapy (ART) regimens, including once daily dosing, but these lag behin...Continue Reading

References

Mar 21, 1998·JAMA : the Journal of the American Medical Association·P E PalumboC J Baker
Jul 6, 2000·Annals of Internal Medicine·D L PatersonN Singh
Jul 29, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K Brinkman
Jan 6, 2001·The Pediatric Infectious Disease Journal·C ReddingtonH W Hsu
Feb 24, 2001·Archives of Disease in Childhood·UNKNOWN Paediatric European Network for Treatment of AIDS (PENTA)
Feb 24, 2001·AIDS·J P TeglasS Blanche
Apr 17, 2001·The Annals of Pharmacotherapy·M E TempleM C Nahata
Dec 12, 2001·The Pediatric Infectious Disease Journal·E KatkoR B Turner
Apr 3, 2002·Pediatrics·Russell B Van DykeUNKNOWN Pediatric AIDS Clinical Trials Group Adherence Subcommittee Pediatric AIDS Clinical Trials Group 377 Study Team
May 1, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Stephen M ArpadiDonald P Kotler
May 3, 2002·Pediatrics·Denise M GaughanUNKNOWN Pediatric AIDS Clinical Trials Group Protocol 219 Team
Jul 3, 2002·Annals of Internal Medicine·Kirk D MillerJoseph A Kovacs
Jul 20, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jean-Jacques CheseauxVincent Mooser
Aug 2, 2002·The Pediatric Infectious Disease Journal·Rene A AmayaMark W Kline
Aug 17, 2002·The Pediatric Infectious Disease Journal·Albert FayeUNKNOWN French Perinatal Study
Oct 24, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Pierre de TruchisUNKNOWN CNAF3008 Group
Nov 20, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Morris SchambelanUNKNOWN International AIDS Society-USA
Jan 25, 2003·The Pediatric Infectious Disease Journal·Catherine LitalienUNKNOWN Paediatric European Network for Treatment of AIDS Executive Committee
Jan 25, 2003·The Pediatric Infectious Disease Journal·Diana M GibbUNKNOWN Paediatric European Network for Treatment of AIDS Steering Committee
Jan 25, 2003·The Pediatric Infectious Disease Journal·Ethan G Leonard, Grace A McComsey
Mar 4, 2003·Pediatrics·George W Brown
Mar 11, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jessica E JustmanKathryn Anastos
Jul 5, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Joegi Thomas, Sheelagh M Doherty
Jul 11, 2003·AIDS·Gwenda VerweelGareth Tudor-Williams
Aug 29, 2003·The New England Journal of Medicine·Jody LawrenceUNKNOWN 064 Study Team of the Terry Beirn Community Programs for Clinical Research on AIDS

❮ Previous
Next ❯

Citations

Nov 21, 2008·The New England Journal of Medicine·Avy ViolariUNKNOWN CHER Study Team
May 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Simone PensierosoPaolo Rossi
Jan 1, 2009·AIDS Care·Mary Haour-Knipe
Dec 15, 2010·AIDS Care·Shankar Das, George S Leibowitz
Jun 7, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thanyawee PuthanakitVirat Sirisanthana
Feb 6, 2008·The Journal of Infectious Diseases·David DunnUNKNOWN Concerted Action on Sero-Conversion to AIDS and Death in Europe (CASCADE) Collaboration
Nov 21, 2008·AIDS Research and Human Retroviruses·Salvador ResinoUNKNOWN Spanish Group of Paediatric HIV Infection
Mar 26, 2010·AIDS Research and Human Retroviruses·C PalladinoMa Angeles Muñoz-Fernández
Sep 3, 2013·AIDS Patient Care and STDs·Ava Lorenc, Nicola Robinson
Jul 4, 2006·AIDS·UNKNOWN HIV Paediatric Prognostic Markers Collaborative Study
Oct 13, 2005·The Pediatric Infectious Disease Journal·Jintanat AnanworanichUNKNOWN HIV-NAT 017 Study Team
Apr 29, 2006·The Pediatric Infectious Disease Journal·Katja DoerholtUNKNOWN Collaborative HIV Paediatric Study
Nov 29, 2007·The Pediatric Infectious Disease Journal·Pablo RojoJose Tomas Ramos
Apr 3, 2008·The Pediatric Infectious Disease Journal·Christoph RudinUNKNOWN Swiss Mother and Child HIV Cohort Study (MoCHiV)
Jun 4, 2008·The Pediatric Infectious Disease Journal·Pope KosalaraksaUNKNOWN HIV-NAT 017 Study Team
Feb 12, 2009·The Pediatric Infectious Disease Journal·Andrew RiordanUNKNOWN Collaborative HIV Paediatric Study
Jul 11, 2008·AIDS·UNKNOWN Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study GroupJens Lundgren
Feb 6, 2009·AIDS·Tessa GoetghebuerUNKNOWN European Infant Collaboration group
May 2, 2009·Current Opinion in Infectious Diseases·Ravindra K GuptaDeenan Pillay
Nov 3, 2009·HIV Medicine·UNKNOWN PENTA Steering CommitteeDiane Bastiaans
Jan 7, 2010·HIV Medicine·S GuillénUNKNOWN Madrid Group for Research on Pediatric HIV Infection
May 20, 2006·BMJ : British Medical Journal·Esse N MensonUNKNOWN Collaborative HIV Paediatric Study Steering Committee
Oct 30, 2008·AIDS Research and Therapy·Jintanat AnanworanichUNKNOWN HIV-NAT 010 Study Team
Mar 28, 2008·PLoS Medicine·Steven B Welch, Di Gibb
Feb 9, 2012·The Indian Journal of Medical Research·S N MothiS M Sarvode
Sep 21, 2007·Current Infectious Disease Reports·Elisa A d'OulxPier-Angelo Tovo
Jun 27, 2006·European Journal of Pediatrics·Eugenia MacassaStéphane Blanche
Oct 23, 2008·European Journal of Pediatrics·Kirsty EnglandMarie-Louise Newell
Jun 2, 2010·Infection·C GiaquintoUNKNOWN Italian Paediatric HIV Infection Working Group
Apr 23, 2011·Lancet·UNKNOWN Pursuing Later Treatment Options II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological ReseaAndrew Phillips
Jan 30, 2008·Cytometry. Part B, Clinical Cytometry·Maurice R G O'Gorman, Lynn S Zijenah

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.